Abionyx Pharma SA banner

Abionyx Pharma SA
PAR:ABNX

Watchlist Manager
Abionyx Pharma SA Logo
Abionyx Pharma SA
PAR:ABNX
Watchlist
Price: 3.695 EUR 0.41%
Market Cap: €131.2m

Wall Street
Price Targets

ABNX Price Targets Summary
Abionyx Pharma SA

Wall Street analysts forecast ABNX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABNX is 10.71 EUR with a low forecast of 10.1 EUR and a high forecast of 11.55 EUR.

Lowest
Price Target
10.1 EUR
173% Upside
Average
Price Target
10.71 EUR
190% Upside
Highest
Price Target
11.55 EUR
213% Upside
Abionyx Pharma SA Competitors:
Price Targets
SANA
Sana Biotechnology Inc
176% Upside
SPWH
Sportsmans Warehouse Holdings Inc
154% Upside

Revenue
Forecast

N/A
Past Growth
72% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
72% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate of Abionyx Pharma SA's revenue for the next 4 years is 72%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABNX's stock price target?
Price Target
10.71 EUR

According to Wall Street analysts, the average 1-year price target for ABNX is 10.71 EUR with a low forecast of 10.1 EUR and a high forecast of 11.55 EUR.

What is Abionyx Pharma SA's Revenue forecast?
Projected CAGR
72%

The compound annual growth rate of Abionyx Pharma SA's revenue for the next 4 years is 72%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett